Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
brainhealth riskfactors lifestyle research Alzheimer's dementia

Text to speech

Clinical Trial Participant Reacts to News Biogen’s Alzheimer’s Drug May Have Been Working

By Being Patient | December 13th, 2019
Clinical Trial Participant Reacts to News Biogen's Alzheimer's Drug Aducanumab May Have Been Working

Biogen has announced new data behind the Alzheimer’s drug aducanumab suggests it was working on early stage patients. Jeff Borghoff was a participant for three years before the company halted the stage three clinical trial. He talks to Being Patient Alzheimer’s about why he felt the drug was working.

If you find our articles and interviews helpful, please consider becoming a supporting member of our community. Frustrated by the lack of an editorially independent source of information on brain health and Alzheimer’s disease, we decided to create Being Patient. We are a team of dedicated journalists covering the latest research on Alzheimer’s, bringing you access to the experts and elevating the patient perspective on what it’s like to live with dementia.

Please help support our mission.

2 thoughts on “Clinical Trial Participant Reacts to News Biogen’s Alzheimer’s Drug May Have Been Working

  1. Is this drug Aducanumab available in Ontario Canada. My husband 73 has dementia diagnosed by his neurologist and gerentologist claims he has Alzheimer’s. Is this drug available to him?

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.